Oncology
6 views | +0 today
Follow
Your new post is loading...
Your new post is loading...
Scooped by Andre da Luz
Scoop.it!

New ultrasound tech could improve cancer detection - CNET

New ultrasound tech could improve cancer detection - CNET | Oncology | Scoop.it
New ultrasound tech could improve cancer detection
CNET
Unfortunately, the high-frequency soundwave approach to viewing soft tissue doesn't provide great resolution, so despite all its perks, it's not the go-to imaging tech for cancer detection.
more...
No comment yet.
Scooped by Andre da Luz
Scoop.it!

Allergies and cancer on the rise due to GM foods - Natural News

Allergies and cancer on the rise due to GM foods - Natural News | Oncology | Scoop.it
Since the 1990s, when genetically modified (GM) foods were approved, we have seen a dramatic increase in food allergies, asthma, ADHD and many forms of cancer. As expected, most corporately-controlled, government ...
Andre da Luz's insight:

There is no evidence to date that indicates that GM foods pose a greater risk than 'natural' foods. We might need to consider looking at the production mechanisms of normal food and the effect these mechanisms have on allergies and cancer to be able to properly compare GM and 'natural' food.

more...
No comment yet.
Scooped by Andre da Luz
Scoop.it!

Cancer therapy is 2013 breakthrough: Science journal

Cancer therapy is 2013 breakthrough: Science journal | Oncology | Scoop.it
A way of fighting cancer that turns the body's immune cells into targeted tumor killers was named the breakthrough of the year by the US journal Science on Thursday.
Andre da Luz's insight:

Very promissing in the treatment (possible cure!) of cancer

more...
No comment yet.
Scooped by Andre da Luz
Scoop.it!

Researchers find potential new treatment approach for pancreatic ...

Researchers find potential new treatment approach for pancreatic ... | Oncology | Scoop.it
Scientists from The University of Manchester – part of Manchester Cancer Research Centre believe they have discovered a new way to make chemotherapy treatment more effective for pancreatic cancer patients.
more...
No comment yet.
Scooped by Andre da Luz
Scoop.it!

Adverse Event Reporting in Cancer Clinical Trial Publications

AE reporting in oncology publications of RCTs suboptimal and characterized by substantial selectivity & heterogeneity http://t.co/xTlewGGBVh
more...
No comment yet.
Scooped by Andre da Luz
Scoop.it!

IBM Watson Demo: Oncology Diagnosis and Treatment (2 min.)

The IBM Watson Cancer Diagnosis and Treatment Adviser demo was created in close collaboration with Memorial Sloan Kettering, one of the world's preeminent ca...
Andre da Luz's insight:

Watch http://www.youtube.com/watch?v=YgYSv2KSyWg as well. 

more...
No comment yet.
Rescooped by Andre da Luz from Social Media and Healthcare
Scoop.it!

One in Four Physicians Uses Social Media Daily

One in Four Physicians Uses Social Media Daily | Oncology | Scoop.it

Oncologists, primary care physicians have different motivations for using social media A new survey shows that about one in four physicians uses social media daily or multiple times a day to scan or explore medical information, and 14 percent use social media each day to contribute new information, according to an oncologist at the Johns Hopkins Kimmel Cancer Center.

The survey of 485 oncologists and primary care physicians, also found that on a weekly basis or more, 61 percent of physicians scan for information and 46 percent contribute new information. More than half said they use online physician-only communities but only 7 percent said they use Twitter. The work was published recently in the Journal of Medical Internet Research.

 

Oncologists are more likely to use social media to keep up with innovation, while primary care physicians are more likely to use social media to get in touch with peers and learn from them, the survey found.

Since the survey was conducted a year and a half ago, it’s likely that more physicians are using social media now, says Robert S. Miller, M.D., an assistant professor of oncology and oncology medical information officer at the Johns Hopkins Kimmel Cancer Center. The amount of information required for medical practice is growing exponentially, he says, and social media provides “a very valid construct for physicians to keep current.”

 

“What did surprise us was the heavy use of online physician-only communities,” Miller says. “It’s possible that many physicians feel more comfortable with that type of social media instead of a more public space like Twitter or Facebook.”

 

In March 2011, Miller and colleagues e-mailed the survey, about attitudes and usage of social media, to a random sample of 1,695 practicing oncologists and primary care physicians found among the American Medical Association’s Physician Masterfile.  Social media was defined as “Internet-based applications that allow for the creation and exchange of user-generated content, including social networking, professional online communities, wikis, blogs and microblogging.”

 

Of 485 practicing physicians who responded, nearly sixty percent said social media is beneficial, engaging and good way to get current, high-quality information (279 respondents); enables them to care for patients more efficiently (281 respondents); and improves the quality of patient care they deliver (291 respondents). What influenced a physician’s usage of social media most were perceived ease of use and usefulness. Physicians who had positive attitudes toward social media were more likely to use it. Neither age nor gender affected use of social media. 

More studies are needed to determine how social media impacts physicians’ knowledge, attitudes, skills and behaviors, and its usage among other populations of health care professionals, Miller says.

The study originated from a common interest in social media among Miller and his co-investigators Brian S. McGowan, Ph.D., Molly Wasko, Ph.D., and Bryan Steven Vartabedian, M.D. Funding for the study was provided by an unrestricted educational grant from Pfizer through McGowan, the lead investigator, who previously was Pfizer’s Director of Oncology Medical Education and is now a medical education consultant and blogger. The research was conducted independently from the funding organization.

 

Coauthors were Brian S. McGowan, Ph.D., of Blue Bell, Pa.; Molly Wasko, Ph.D., of the University of Alabama; Bryan Steven Vartabedian, M.D., of Baylor College of Medicine; and Desirae D. Freiherr and Maziar Abdolrasulnia, Ph.D., of CE Outcomes, LLC, of Birmingham, Ala.


Via Plus91
more...
No comment yet.
Scooped by Andre da Luz
Scoop.it!

Pharma chief: Governments must stop thinking short-term - EurActiv

Pharma chief: Governments must stop thinking short-term - EurActiv | Oncology | Scoop.it
Pharma chief: Governments must stop thinking short-term EurActiv The EU must continue to invest in the pharmaceutical industry, where Europe has been a leader for many years, but where it's becoming more and more difficult to bring products to the...
more...
No comment yet.